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Abstract
Background: Current diagnostic methods for Schistosoma japonicum infection are insensitive for low-density
infections. Therefore, a new diagnostic assay based on recombinase polymerase amplification (RPA) technology was
established and assessed for field applification.
Methods: The S.japonicum RPA assay was developed to target highly repetitive retrotransposon SjR2 gene of S
japonicum, and its sensitivity and specificity were assessed by serial dilution of S. japonicum genomic DNA and
other related worm genomic DNA respectively. The RPA diagnostic validity was first evaluated in 60 fecal samples
from healthy people and patients, and then compared with other diagnostic tests in 200 high-risk individuals living
in endemic areas.
Results: The real time RPA assay could detect 0.9 fg S. japonicum DNA within 15 min and distinguish S. japonicum
from other worms. The validity analysis of RPA for the detection of S. japonicum in stool samples from 30
S. japonicum-infected patients and 30 healthy persons indicated 100% sensitivity and specificity. When testing
200 fecal or serum samples from a high-risk population, the percentage sensitivity of RPA was 100%, whereas
that of indirect hemagglutination assay (IHA) and enzyme-linked immunosorbent assay (ELISA) were 80.3% and 85.2%
respectively. In addition, the RPA presented better consistency with the stool-based tests than IHA and ELISA. Overall,
the RPA was superior to other detection methods with respect to detection time, sensitivity, and convenience.
Conclusions: This is the first time we applied the RPA technology to the field evaluation of S. japonicum infection.
And the results suggest that RPA-based assays can be used as a promising point-of-care test for the diagnosis of
schistosomiasis.
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Background
Schistosomiasis japonica is a major tropical disease in
China, with a >2100-year documented history [1]. With
the implementation of the National Control Program
supported by the Chinese government, China has made
great progress in reducing S. japonicum infections in
humans [2–5]. Today, the prevalence is becoming more
and more low in most of the endemic areas. Under such
circumstances, current diagnostic methods became less
sensitive and specific which make the control program
in a difficult situation. Generally, S. japonicum infections
are diagnosed by direct parasitological methods or im-
munological methods. Parasitological detections, includ-
ing the Kato-Katz (KK) thick smear and the miracidium
hatching test (MHT), were regarded as golden standard
for the diagnosis of schistosomiasis. However, parasito-
logical detection is labor-intensive, time-consuming,
and exhibits low sensitivity, which is not suitable for
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large-scale disease surveillance [6, 7]. Immunological
methods include indirect hemagglutination assay (IHA)
and enzyme-linked immunosorbent assay (ELISA). Both
of them are more sensitive and convenient than para-
sitological methods. However, the above immunologic
detection methods are usually not species-specific and
can not discriminate between the active and past S.
japonicum infection. Many studies demonstrated that
false-positive rates of IHA and ELISA were very high in
field settings [8–11]. Recently, Pan et al. verified a po-
tential protein marker, SjSP-13, using genome-wide
methods, and the SjSP-13-based ELISA kit showing
90.4% sensitivity and 98.9% specificity in a field study.
However, its validity still needs further confirmation in
large-scale population studies [12]. Given that the cur-
rently available diagnostic methods are not very satis-
factory, development and evaluation of new strategies
and tools for the control of schistosomiasis were rec-
ommended by the World Health Organization [13].
With the development of nucleic amplification tech-
nology, polymerase chain reaction (PCR) and other
isothermal amplification technologies have been de-
scribed for the diagnosis of schistosomiasis [14, 15].
Although PCR-based assays provide sensitive, specific
and reliable tools, they are not widely utilized due to
the dependence on expensive apparatus and training
operator, which limits their large-scale application for
clinical diagnosis [16].
In 2006, Piepenburg et al introduced a novel isother-
mal technology called recombinase polymerase ampli-
fication (RPA) for molecular diagnosis [17]. Unlike
many other amplification methods, RPA does not
require thermal denaturation of template but utilizes
recombinase enzyme with opposing oligonucleotide
primers to scan duplex DNA and facilitate strand
exchange at cognate sites. The reaction progresses
rapidly and results in specific DNA amplification from
just a few target copies to detectable levels typically at
temperatures between 25 °C and 42 °C. With RPA
probes which contain a specific abasic nucleotide
analogue flanked by a dT-fluorophore and a corre-
sponding dT-quencher group, we can monitor ampli-
cation events in the reaction [17]. Since RPA has
advantages, including a broad range of incubation
temperatures (25–42 °C), shorter reaction times (typ-
ically <15 min), and more flexibility in basic laboratory
settings in the field, it has gained further attention in
point-of-care testing.
Here, we developed a real-time RPA assay for
rapid detection of S. japonicum DNA in fecal
samples and compared this assay with current
methods in terms of sensitivity and specificity for
the diagnosis of S. japonicum infection in high-risk
populations.
Methods
RPA primer and probe
The highly repetitive retrotransposon SjR2 of S. japoni-
cum (GenBank accession No. AF412221) was used for
DNA detection as a target sequence [18–20]. The
SjR2-specific primers and probe for RPA were designed
according to Piepenburg [17], and the optimal combin-
ation of primers and probe were shown in Table 1. All
oligonucleotides were produced by Sangon Biotech,
Beijing, China.
DNA extraction
Samples of genomic DNA were extracted from the
adult worms of S. japonicum, S. haematobium, S. man-
soni, and S. sinensium by a DNeasy Tissue Kit (Qiagen,
CA, USA) following the manufacturer’s instruction.
The concentration and purity of the DNA were deter-
mined spectrophotometrically by readings at wavelengths
of 260 nm and 280 nm (Eppendorf BioSpectrometer,
Hamburg, Germany).
RPA reactions
RPA was performed in a total volume of 50 μL, using a
TwistAmp Exo kit (TwistDX Ltd., Cambridge, UK). Each
reaction contained 29.5 μl TwistAmp rehydration buffer,
2.1 μl each RPA primer (210nM), 0.6 μl RPA probe
(120nM), 12.2 μl nuclease-free water, 1 μl template and
2.5 μl magnesium acetate. All reagents except for the
magnesium acetate and template DNA were pipette into
a 0.2 ml reaction tube which contains a dried enzyme
pellet. To start the reaction magnesium acetate and tem-
plate DNA were added. Then the tube was placed in the
TwistaTM incubator block (39 °C) and the fluorescence
measurement was initiated to minitor the progression of
RPA reactions. The preincubation was performed for
1 min and followed by incubation for 20 min, with brief
mixing of the mixtures after a 4 min incubation step. In
combination with the nuclease sensitive fluorophore/
quencher probes, a real-time DNA detection system was
constituted. The labeled amplicon that generated in the
reaction can be measured via 6-carboxyfluorescein
(FAM) fluorescence using the Twista™ reader every 20 s.
Table 1 RPA primers and probe designed in this study
Name Sequence
S. japonicum RPA FP CCAAGTCTCAGTGAAGTTGTGAAGGCTAT
S. japonicum RPA RP GTTAGTGTTCGAGACCAGTCAGATGGGATT
S. japonicum RPA P CTTAAAGCGAGGGAGAGCGGCAGGACCAGA
(dT-FAM)G(THF)A(dT-BHQ1)TGACCCCTG
AGATAT[3’-block]
FP forward primer, RP reverse primers, P probe, dT-FAM thymidine nucleotide
carrying fluorescein, THF tetrahydrofuran spacer, dT-BHQ1 thymidine
nucleotide carrying black hole quencher
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The RPA fluorescence data were assessed by taking a
baseline relative fluorescence unit measurement.
Real-time PCR
Real-time PCR was performed using SYBR Green Mas-
termix (Fermentas, Ontario, Canada) and the ABI 7500
QPCR system according to manufacturer instructions.
All samples were processed in triplicate. Primers used in
amplifications were as follows: SJR2: 5′-GAC AGG TTC
TGG AAC ATA GG-3′; SJR2: 5′-GGT CAA TTC CGA
AGA CAA TC3′.
Sensitivity and specificity tests
The sensitivity of the RPA-assay was evaluated using five
10-fold serial dilutions ranging from 9 pg/μL to 0.9 fg/
μL genomic DNA extracted from an S. japonicum worm.
The specificity of detection was performed using gen-
omic DNA from S. japonicum, S. haematobium, S. man-
soni, and S. sinensium.
Analysis of RPA diagnostic validity
Thirty infected fecal samples collected from Xiangyue
Hospital in Yueyang city were diagnosed by the KK
method as egg-positive. The other thirty uninfected fecal
samples were collected from health volunteers living in
the Haidian District of Beijing, where schistosomiasis is
not endemic. We then used RPA technology to analyze
the fecal samples and assess the sensitivity and specifi-
city of the RPA system.
Field evaluation
Two-hundred fishermen living in Yueyang County near
Dongting Lake in the northeastern region of Hunan
Province were enrolled in the field study to examine the
potential diagnostic value. The inhabitants became in-
fected with S. japonicum owing to frequent agricultural
activities and fishing in snail-infested marshlands.. Total
DNA from 500 mg of fecal sample of each participant
was extracted using the QIAamp DNA Stool Mini Kit
(Qiagen GmbH, Hilden, Germany) according to manu-
facturer instructions. The other fecal sample from each
participant was analyzed with MHT and KK. 3 mL blood
sample was collected from each participant and was cen-
trifuged as 760 × g at 4 °C for 10 min. The obtained
serum samples were stored as -80 °C for ELISA and
IHA measurement.
MHT and KK thick smear
The MHT was performed by adding about 30 g of feces
into a metal container with a coarse wire mesh (150
holes per square inch). With the flowing water and a
stirring stick, fine material was flushed into a 300-mesh
nylon bag and flushed with water until the sediment was
clear. Then the sediment was collected and transferred
to a triangular flask containing 300 mL non-chlorinated
water from the Yangtze River. Finally, the flasks were left
in a well-lit room with the temperature set at approxi-
mately 28 °C and examined with a magnifying glass to
check the present of swimming miracidia after 4, 6, 8,
and 24 h.
The KK thick smear was performed according to a
standardized methodology [21]. The method based on
three slides by using fresh stool specimen, nylon screens
and plastic templates (Zhejiang Ningbo Medical Instru-
ment Factory, Ningbo, China). The three slides (41.7 mg
each) were prepared from one stool sample and exam-
ined within 1 week. The intensity of infection was calcu-
lated by multiplying the number of eggs per glass slide
by 24.
ELISA and IHA
S. japonicum IgG ELISA kit (BIOCBD, Shenzhen, China)
was used to detect the infection status of the high-risk
population. All procedures were conducted according to
manufacturer instructions. The IHA detection kit was
purchased from Anhui Provincial Institute of Parasitic
Diseases (Wuhu, China). The testing procedure was per-
formed as described by Zhou et al [8]. The test result
was recognized to be positive when a positive reaction
appeared at an antibody titer of ≥1:10.
Statistical analysis
In the field survey, the combination of the KK method
and the MHT was considered the diagnostic gold stand-
ard, and the diagnostic performance of RPA was
assessed by calculating sensitivity, specificity, positive
predictive value (PPV), and negative predictive value
(NPV). The indexes were calculated using SAS 9.2 soft-
ware (SAS Institute, Inc., Cary, NC, USA), and agree-
ment statistics were determined (JMP v9, SAS Institute
Inc.) to establish the agreement between two diagnostic
tests. A p < 0.05 was considered significant.
Results
Sensitivity and specificity of the RPA assay for
S. japonicum
The analytical sensitivity of the assay was evaluated with
10-fold serial dilutions ranging from 9 pg/μL to 0.9 fg/
μL of genomic DNA extracted from an S. japonicum
worm. The results showed that the RPA limit of detec-
tion was 0.9 fg DNA per reaction, which is equal to that
of real-time PCR (Fig. 1a and b). Although the RPA sen-
sitivity was equal to real-time PCR, the former was far
superior to the latter in detection time and convenience.
RPA specificity for S. japonicum was confirmed by
cross-detection assays using the genomic DNA of S.
mansoni, S. sinensium, and S. haematobium, while none
of these was amplified (Fig. 2).
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Analysis of RPA diagnostic validity
We analyzed RPA diagnostic validity using 30 in-
fected and 30 uninfected fecal samples. Compared to
KK method, RPA diagnostic sensitivity and specificity
were both 100% for stool samples (Table 2). This
result indicated that the RPA method was valid for
S. japonicum diagnosis.
Comparison of the RPA assay, ELISA, IHA, MHT and
the modified KK method in terms of sensitivity and
specificity for the detection of S. japonicum infection
in the field study
To further assess the RPA assay, we performed a field
study to evaluate its sensitivity and specificity. The
RPA diagnostic validity was compared with that of
ELISA, IHA, the MHT and the modified KK method.
Two-hundred inhabitants were enrolled in the study,
including 92 male and 108 female participants.
Among these, 164 (82%) were aged 15–54 years, and
36 (18%) were aged 55–78 years, and the local fisher-
men were assessed between March 2013 and April
2014. Of the 200 enrolled residents, 61 (31.5%) indi-
viduals were identified as being positive using the
MHT, which included 48 (24%) individuals tested
positive using the KK method. All individuals diagnosed
as positive for parasitological infection were also diag-
nosed as being positive by RPA detection (Fig. 3). In
conclusion, the RPA identified more positive cases than
either, including samples negative by the other tech-
niques (Table 3). Here, the combination of the KK and
MHT methods was considered the diagnostic gold
standard. The sensitivity and specificity of ELISA and
IHA were 85.2% and 93.5%, 80.3% and 83.4% respect-
ively, while RPA sensitivity and specificity was 100%
Fig 1 Analytical sensitivity of real-time RPA and real-time PCR for Schistosoma japonicum detection. Fluorescence development via real-time
detection using a dilution range of 9 pg/μL–0.9 fg/μL of the S. japonicum genomic DNA. a Real-time RPA: 9 pg/μL, represented by the red line;
900 fg/μL, green; 90 fg/μL, pink; 9 fg/μL, cyan; 0.9 fg/μL, blue; negative control, black. b Real-time PCR: 9 pg/μL represented by the red line;
900 fg/μL, orange; 90 fg/μL, light green; 9 fg/μL, green; 0.9 fg/μL, cyan; negative control, pink
Fig 2 The specificity of Schistosoma japonicum RPA. S. japonicum is represented by the blue line; S. mansoni, black; S. sinensium, green; S. haematobium, pink
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and 96.4%, respectively (Table 3). In addition, the RPA
showed a significantly higher degree of agreement with
the gold standards (kappa: 0.942; 95% confidence interval
(CI): 0.89–0.99; p < 0.001) relative to IHA and ELISA
[IHA kappa: 0.61 (95% CI: 0.49–0.72), p < 0.001; ELISA
kappa: 0.78 (95% CI: 0.69–0.88), p < 0.001] (Table 4).
Discussion
The global schistosomiasis control program has made
tremendous progress in reducing the prevalence of the
disease and morbidity in many endemic areas, particu-
larly in China [22]. However, the complete elimination
of schistosomiasis associated with S. japonicum and
the prevention of its reemergence remain difficult due
to the limitations of detection methods [23]. There-
fore, it is necessary to develop an efficient and
convenient detection method for overall control of
schistosomiasis infection.
Recently, related DNA-amplification technologies, in-
cluding PCR, real-time PCR, and isothermal nucleic acid
amplification, were developed to detect S. japonicum
infections and showed potential as highly sensitive and
specific techniques for the detection of parasite DNA in
feces or sera, especially in regions with low-intensity in-
fections. However, PCR and real-time PCR were ex-
tremely dependent on a well-equipped laboratory,
given that testing times usually take 60–90 min, and
the equipment is heavy, expensive, complex, and must
be operated by qualified staff. Additionally, the draw-
backs of isothermal amplification methods such as
LAMP are as follows: the design of appropriate
LAMP primers is more complicated than that of PCR
and RPA primers, and LAMP requires higher incuba-
tion temperatures ranging from 55 °C to 65 °C for
60–75 min, with the amplification products difficult
to quantify [24].
In this study, RPA technology was used to detect
S. japonicum infection, with the diagnostic method
revealing substantial advantages over current
methods. First, RPA showed adequate sensitivity and
specificity required for identification of low-intensity
infections. The RPA limit of detection reached 0.9 fg
per reaction, which was equal to real-time PCR. The
non-long terminal repeat (LTR) retrotransposons
(SjR2) was chose as detection targets, which were
highly conserved and repeatable in the S. japonicum
genome [20]. And we found there was no cross-
reactivity with other fluke infections. Second, the
RPA technique combined with the fluorescent probe
achieved detection within 10–15 min, which was a
much shorter duration relative to that of current
methods. Third, the RPA can be operated at a rela-
tive low and constant temperature and the only re-
quirements are primers, the probe, and the sample,
while others can be stored in lyophilized form, which
facilitates field testing or point-of-care applications.
The above advantages make RPA more suitable for
the application in field study or point of care test.
Recently a LFD-RPA assay which combine recombin-
ase polymerase amplification and lateral flow dipstick
was also developed. It adopted a lateral flow system
to readout the results with naked eyes which seemed
really rapid and applicable in field. Nevertheless,
current LFD-RPA assay requires additional steps to
transfer the amplified product to another opened
tube for lateral flow detection, which may lead to
the possibility of nucleic acid contamination [25, 26].
Therefore, the LFD-RPA assay still needs to be
further improved for practical application.
Further, the validity analysis for RPA in the detec-
tion of S. japonicum in the stool samples from 30
controls and 30 cases indicated that the method
exhibited excellent sensitivity and specificity. There-
fore, RPA technology was then applied in the field
survey of S. japonica infection and compared with
current detection methods. The field study showed
that the RPA assay identified 66 enrolled participants
as positive, which included all individuals diagnosed
as positive by the MHT and KK methods. Among all
the participants, RPA technique identified 33% of
Table 2 Analysis of diagnostic validity of RPA
Subjects Investigated RPA-positive
Controls (negative by KK method) 30 0 (0%)
Cases (positive by KK method) 30 30 (100%)
Fig 3 Agreement between RPA, Kato-Katz thick smear and MHT for
stool-based diagnosis of Schistosoma japonicum infections. Values
indicate the number of positive samples in each group
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infection intensity, while the KK method only identi-
fied only 24% of infection intensity. Furthermore,
when the combination of the KK method and the
MHT was regarded as the diagnostic golden stan-
dard,RPA sensitivity and specificity was 100% and
96.4%, respectively, which was significantly superior
to that of the IHA and ELISA methods. However, a
significant drawback of RPA technology is its high
cost per reaction. The primers and RPA exo reaction
kits together cost approximately $4.3, which was
higher than current detection technology. Of course,
with availability and throughput increase, the prices
are likely to decrease in the future. Besides, some
more simple and cheap DNA extraction methods are
considering in our next field work, such as the com-
mercially available magnetic bead-based strategy, non-
commercial ROSE extraction method and heated
NaOH method. All these considering methods are
cheap and easy to perform which will greatly decrease
the whole cost.
Conclusion
In this study, we developed an RPA assay for detec-
tion of S. japonicum and firstly applied it to epi-
demiological studies. Our results showed that the
RPA assay was a very attractive nucleic acid detection
method for the diagnosis of S. japonicum infection.
This method exhibited high sensitivity, good specifi-
city, convenient operation, minimal equipment re-
quirement and rapid detection. And it could be
applicable to not only schistosomiasis diagnosis but
also environmental monitoring.
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